Invivyd
Company

Invivyd

Biotechnology Research 1601 Trapelo Rd 107 employees IVVD
Employees
107
Contacts
3
Emails
3
Phones
1

Invivyd Overview

Headquarters
1601 Trapelo Rd
Website
www.invivyd.com
Industry
Biotechnology Research
Employees
107
Founded
2020
Stock Symbol
IVVD
Funding
30.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Invivyd

Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more. #covid19 #immunocompromised

Invivyd Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

Invivyd Org Chart

Sample employees and titles
Name Title Contact
Paul Grous Head of IT, Invivyd
Email Phone
Danielle Looney
Email
John Landry
View
William Duke
Email

Compare Similar Companies to Invivyd